Intelligent Bio Solutions Inc.
INBS
$0.66
-$0.01-1.58%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 31.75% | 15.78% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 31.75% | 15.78% | |||
| Cost of Revenue | 16.76% | 31.17% | |||
| Gross Profit | 54.44% | -1.70% | |||
| SG&A Expenses | -2.15% | 12.90% | |||
| Depreciation & Amortization | 1.03% | -0.56% | |||
| Other Operating Expenses | 49.65% | -121.52% | |||
| Total Operating Expenses | 3.33% | 13.51% | |||
| Operating Income | 4.99% | -12.86% | |||
| Income Before Tax | 3.47% | -21.64% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 3.47% | -21.64% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -4.00% | 76.06% | |||
| Net Income | 3.47% | -21.49% | |||
| EBIT | 4.99% | -12.86% | |||
| EBITDA | 5.98% | -13.90% | |||
| EPS Basic | 20.95% | -0.18% | |||
| Normalized Basic EPS | 22.34% | 7.05% | |||
| EPS Diluted | 20.95% | -0.18% | |||
| Normalized Diluted EPS | 22.34% | 7.05% | |||
| Average Basic Shares Outstanding | 22.11% | 21.26% | |||
| Average Diluted Shares Outstanding | 22.11% | 21.26% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||